C4 Therapeutics, Inc.
CCCC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $55 | $127 | $30 | $76 |
| Short-Term Investments | $189 | $127 | $246 | $233 |
| Receivables | $3 | $12 | $1 | $6 |
| Inventory | $0 | $0 | -$61 | $0 |
| Other Curr. Assets | $10 | $6 | $71 | $11 |
| Total Curr. Assets | $258 | $271 | $288 | $326 |
| Property Plant & Equip (Net) | $63 | $71 | $78 | $35 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $22 | $28 | $61 | $142 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $6 | $5 | $4 |
| Total NC Assets | $92 | $105 | $143 | $181 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $350 | $376 | $431 | $507 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $5 |
| Short-Term Debt | $6 | $5 | $7 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $19 | $15 | $17 | $32 |
| Other Curr. Liab. | $19 | $21 | $20 | $14 |
| Total Curr. Liab. | $45 | $43 | $45 | $51 |
| LT Debt | $60 | $66 | $80 | $42 |
| Deferred Rev, NC | $28 | $22 | $17 | $24 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $88 | $88 | $97 | $66 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $66 | $71 | $76 | $32 |
| Total Liabilities | $134 | $130 | $142 | $117 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$634 | -$528 | -$396 | -$268 |
| AOCI | $0 | -$0 | -$4 | -$1 |
| Other Equity | $850 | $775 | $689 | $658 |
| Total Equity | $216 | $246 | $289 | $390 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $350 | $376 | $431 | $507 |
| Net Debt | $10 | -$56 | $57 | -$33 |